Trial intelligence / Profile preview

Chemotherapy vs Hormonal Therapy in Advanced Endometrial Cancer

NCT00016341Phase 3Terminated

Sponsor
GOG Foundation
Start
May 2001
Primary completion
Oct 2003
Modality
DNA Intercalators/Alkylators
Countries
2
01

Overview

A Phase 3 trial of doxorubicin, cisplatin, paclitaxel, megestrol, tamoxifen in endometrial cancer (EC), sponsored by GOG Foundation. Started May 2001; status: terminated.

02

Drugs

doxorubicincisplatinpaclitaxelmegestroltamoxifen
03

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on NCT00016341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00016341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call